Published in Ann Surg on May 01, 2003
Stem cell mobilization is life saving in an animal model of acute liver failure. Ann Surg (2010) 2.19
Management of acute liver failure. Nat Rev Gastroenterol Hepatol (2009) 1.32
Clinical application of bioartificial liver support systems. Ann Surg (2004) 1.24
Population-based epidemiology of intensive care: critical importance of ascertainment of residency status. Crit Care (2004) 1.14
Prediction of poor outcome in patients with acute liver failure-systematic review of prediction models. PLoS One (2012) 0.95
Aetiology and outcome of acute liver failure. HPB (Oxford) (2009) 0.91
Point-of-care continuous (13)C-methacetin breath test improves decision making in acute liver disease: results of a pilot clinical trial. World J Gastroenterol (2009) 0.90
Dynamic tracking of stem cells in an acute liver failure model. World J Gastroenterol (2012) 0.87
Survival predictors in patients treated with a molecular adsorbent recirculating system. World J Gastroenterol (2009) 0.82
Prediction of survival after liver transplantation for chronic severe hepatitis B based on preoperative prognostic scores: a single center's experience in China. World J Surg (2009) 0.81
Acute liver failure and liver transplantation. Intractable Rare Dis Res (2013) 0.81
Fulminant liver failure model with hepatic encephalopathy in the mouse. Ann Gastroenterol (2011) 0.80
Cadaveric liver transplantation for non-acetaminophen fulminant hepatic failure: a 20-year experience. World J Gastroenterol (2007) 0.78
Acute liver failure: a management challenge for the practicing gastroenterologist. Gastroenterol Hepatol (N Y) (2010) 0.75
Liver transplantation in acute liver failure: A challenging scenario. World J Gastroenterol (2016) 0.75
Selectivity of biopolymer membranes using HepG2 cells. Regen Biomater (2015) 0.75
Intercontinental comparison of patient cohorts: what can we learn from it? Gut (2007) 0.75
Early indicators of prognosis in fulminant hepatic failure. Gastroenterology (1989) 7.43
Acute liver failure: redefining the syndromes. Lancet (1993) 4.99
Acute liver failure. N Engl J Med (1993) 3.81
Emergency liver transplantation for acute liver failure. Evaluation of London and Clichy criteria. J Hepatol (1993) 3.24
Etiology and outcome for 295 patients with acute liver failure in the United States. Liver Transpl Surg (1999) 2.79
Treatment of hepatic encephalopathy. N Engl J Med (1997) 2.60
Fulminant hepatic failure: summary of a workshop. Hepatology (1995) 2.53
Fulminant and subfulminant liver failure: definitions and causes. Semin Liver Dis (1986) 2.39
Acute liver failure: clinical features, outcome analysis, and applicability of prognostic criteria. Liver Transpl (2000) 1.88
Causes of death in fulminant hepatic failure and relationship to quantitative histological assessment of parenchymal damage. Q J Med (1975) 1.82
A 10-year experience of liver transplantation for hepatitis C: analysis of factors determining outcome in over 500 patients. Ann Surg (2001) 1.73
Hepatic transplantation in Europe. First Report of the European Liver Transplant Registry. Lancet (1987) 1.68
Multivariate analysis of prognostic factors in fulminant hepatitis B. Hepatology (1986) 1.59
Liver transplantation for fulminant hepatic failure. Semin Liver Dis (1985) 1.56
Emergency liver transplantation for fulminant hepatitis. Ann Intern Med (1987) 1.56
Orthotopic liver transplantation for acute and subacute hepatic failure in adults. Hepatology (1987) 1.53
A bioartificial liver--state of the art. Science (2002) 1.53
Use and outcome of liver transplantation in acetaminophen-induced acute liver failure. Hepatology (1998) 1.48
Split liver transplantation. Ann Surg (1999) 1.46
Orthotopic liver transplantation in fulminant and subfulminant hepatitis. The Paul Brousse experience. Ann Surg (1995) 1.45
Liver transplantation in the management of fulminant hepatic failure. Gastroenterology (1989) 1.35
Outcome of orthotopic liver transplantation in the aetiological and clinical variants of acute liver failure. Q J Med (1988) 1.24
Liver transplantation for fulminant hepatic failure. Arch Surg (1993) 1.23
Fulminant hepatic failure: the role of liver transplantation as primary therapy. Am J Surg (1987) 1.22
Pretransplant model to predict posttransplant survival in liver transplant patients. Ann Surg (2002) 1.22
Prognostic evaluation of early indicators in fulminant hepatic failure by multivariate analysis. Dig Dis Sci (1998) 1.19
Emergency liver transplantation for fulminant liver failure in infants and children. Hepatology (1992) 1.03
A simple model to estimate survival after retransplantation of the liver. Transplantation (1999) 1.02
Liver transplantation in Europe for patients with acute liver failure. Semin Liver Dis (1996) 1.00
The use of ABO-incompatible grafts in liver transplantation: a life-saving procedure in highly selected patients. Transplantation (1995) 0.99
Liver transplantation for fulminant hepatic failure. Transplant Proc (1989) 0.98
Recommendations of the International Association for the Study of the Liver Subcommittee on nomenclature of acute and subacute liver failure. J Gastroenterol Hepatol (1999) 0.95
Liver transplantation for fulminant hepatic failure in the pediatric patient. Arch Surg (1998) 0.94
Pretransplantation clinical status and outcome of emergency transplantation for acute liver failure. Hepatology (1995) 0.87
The American experience with transplantation for acute liver failure. Semin Liver Dis (1996) 0.86
The importance of orthotopic liver transplantation in acute hepatic failure. Transpl Int (2002) 0.86
Primary graft dysfunction after liver transplantation: from pathogenesis to prevention. Liver Transpl Surg (1997) 0.84
Prospects for the temporary treatment of acute liver failure. Eur J Gastroenterol Hepatol (2002) 0.80
Transplantation for fulminant hepatic failure: comparing tacrolimus versus cyclosporine for immunosuppression and the outcome in elective transplants. European FK506 Liver Study Group. Transplantation (1996) 0.77
Liver transplantation in acute fulminant hepatic failure. Transplant Proc (1987) 0.77
Liver transplantation for acute and subacute fulminant hepatic failure. Transplant Proc (1989) 0.77
Liver transplantation for fulminant hepatitis at Stanford University. J Gastroenterol (2002) 0.77
Liver transplantation for acute liver failure in children under 1 year of age. Transplant Proc (1997) 0.77
Hepatitis C virus infection in USA: an estimate of true prevalence. Liver Int (2011) 3.36
Cutting edge: TLR4 activation mediates liver ischemia/reperfusion inflammatory response via IFN regulatory factor 3-dependent MyD88-independent pathway. J Immunol (2004) 3.27
Donor and recipient outcomes in right lobe adult living donor liver transplantation. Liver Transpl (2002) 2.98
Hepatic ischemia/reperfusion injury--a fresh look. Exp Mol Pathol (2003) 2.81
Improvement in survival associated with adult-to-adult living donor liver transplantation. Gastroenterology (2007) 2.72
Atorvastatin and antioxidants for the treatment of nonalcoholic fatty liver disease: the St Francis Heart Study randomized clinical trial. Am J Gastroenterol (2010) 2.63
Complications and use of intracranial pressure monitoring in patients with acute liver failure and severe encephalopathy. Liver Transpl (2005) 2.63
Evidence-based incorporation of serum sodium concentration into MELD. Gastroenterology (2006) 2.62
Arboviral etiologies of acute febrile illnesses in Western South America, 2000-2007. PLoS Negl Trop Dis (2010) 2.60
Identification of a therapeutic strategy targeting amplified FGF19 in liver cancer by Oncogenomic screening. Cancer Cell (2011) 2.56
ASC/caspase-1/IL-1β signaling triggers inflammatory responses by promoting HMGB1 induction in liver ischemia/reperfusion injury. Hepatology (2013) 2.45
Safety and efficacy of a single bolus administration of recombinant factor VIIa in liver transplantation due to chronic liver disease. Liver Transpl (2005) 2.35
Blockade of Janus kinase-2 signaling ameliorates mouse liver damage due to ischemia and reperfusion. Liver Transpl (2010) 2.30
Outcomes of living donor liver transplantation for acute liver failure: the adult-to-adult living donor liver transplantation cohort study. Liver Transpl (2008) 2.30
Incisional hernia after liver transplantation. J Am Coll Surg (2006) 2.23
Chapare virus, a newly discovered arenavirus isolated from a fatal hemorrhagic fever case in Bolivia. PLoS Pathog (2008) 2.23
An explicit quality indicator set for measurement of quality of care in patients with cirrhosis. Clin Gastroenterol Hepatol (2010) 2.18
Surgical privileging and credentialing: a report of a discussion and study group of the American Surgical Association. J Am Coll Surg (2009) 2.18
Telephone intervention with family caregivers of stroke survivors after rehabilitation. Stroke (2002) 2.18
Vascular complications of orthotopic liver transplantation: experience in more than 4,200 patients. J Am Coll Surg (2009) 2.16
Evaluation of the cost-effectiveness of entecavir versus lamivudine in hepatitis BeAg-positive chronic hepatitis B patients. J Manag Care Pharm (2008) 2.16
Ammonia levels and the severity of hepatic encephalopathy. Am J Med (2003) 2.14
Liver transplantation in highest acuity recipients: identifying factors to avoid futility. Ann Surg (2014) 2.13
Donor-specific HLA Antibodies Are Associated With Late Allograft Dysfunction After Pediatric Liver Transplantation. Transplantation (2015) 2.13
Liver transplantation criteria for hepatocellular carcinoma should be expanded: a 22-year experience with 467 patients at UCLA. Ann Surg (2007) 2.12
A 1-year trial of telbivudine, lamivudine, and the combination in patients with hepatitis B e antigen-positive chronic hepatitis B. Gastroenterology (2005) 2.08
Radiofrequency ablation of hepatocellular carcinoma: treatment success as defined by histologic examination of the explanted liver. Radiology (2005) 2.04
Surgery for hepatocellular carcinoma: does it improve survival? Ann Surg Oncol (2004) 2.01
Acetaminophen hepatotoxicity and acute liver failure. J Clin Gastroenterol (2009) 1.97
Genome-scale multilocus microsatellite typing of Trypanosoma cruzi discrete typing unit I reveals phylogeographic structure and specific genotypes linked to human infection. PLoS Pathog (2009) 1.91
Immunosuppression and the risk of post-transplant malignancy among cadaveric first kidney transplant recipients. Am J Transplant (2004) 1.90
Macrovesicular hepatic steatosis in living related liver donors: correlation between CT and histologic findings. Radiology (2004) 1.80
MELD fails to measure quality of life in liver transplant candidates. Liver Transpl (2005) 1.79
Prospective, randomized, multicenter, controlled trial of a bioartificial liver in treating acute liver failure. Ann Surg (2004) 1.79
Analysis of long-term outcomes of 3200 liver transplantations over two decades: a single-center experience. Ann Surg (2005) 1.73
Hepatocellular carcinoma screening in patients waiting for liver transplantation: a decision analytic model. Liver Transpl (2003) 1.71
Predicting poor outcome following hepatectomy: analysis of 2313 hepatectomies in the NSQIP database. HPB (Oxford) (2009) 1.70
Outcome of liver transplantation in septuagenarians: a single-center experience. Arch Surg (2007) 1.69
Percutaneous radiofrequency ablation of hepatocellular carcinoma as a bridge to liver transplantation. Hepatology (2005) 1.66
Aggressive resection of hepatocellular carcinoma with right atrial involvement. Am Surg (2009) 1.66
Endoscopic treatment of postorthotopic liver transplantation anastomotic biliary strictures with maximal stent therapy (with video). Gastrointest Endosc (2010) 1.65
Recurrence of hepatocellular carcinoma following liver transplantation: a review of preoperative and postoperative prognostic indicators. Arch Surg (2008) 1.65
Assessment of hepatic steatosis by transplant surgeon and expert pathologist: a prospective, double-blind evaluation of 201 donor livers. Liver Transpl (2013) 1.62
Chronic viral hepatitis and hepatocellular carcinoma. World J Surg (2007) 1.62
The protective function of neutrophil elastase inhibitor in liver ischemia/reperfusion injury. Transplantation (2010) 1.62
Ex vivo exposure to carbon monoxide prevents hepatic ischemia/reperfusion injury through p38 MAP kinase pathway. Hepatology (2002) 1.62
Neuropeptide PACAP in mouse liver ischemia and reperfusion injury: immunomodulation by the cAMP-PKA pathway. Hepatology (2013) 1.60
Type I, but not type II, interferon is critical in liver injury induced after ischemia and reperfusion. Hepatology (2008) 1.59
Outcomes in hepatitis C virus-infected recipients of living donor vs. deceased donor liver transplantation. Liver Transpl (2007) 1.58
Operative parameters that predict the outcomes of hepatic transplantation. J Am Coll Surg (2003) 1.58
Giant cavernous liver hemangiomas: effect of operative approach on outcome. Arch Surg (2004) 1.58
Predictors of hyperkalemia in the prereperfusion, early postreperfusion, and late postreperfusion periods during adult liver transplantation. Anesth Analg (2007) 1.57
Serum ferritin concentration predicts mortality in patients awaiting liver transplantation. Hepatology (2010) 1.56
Metalloproteinase-9 deficiency protects against hepatic ischemia/reperfusion injury. Hepatology (2008) 1.55
Liver transplantation for nonalcoholic steatohepatitis: the new epidemic. Ann Surg (2012) 1.55
A caspase inhibitor, IDN-6556, ameliorates early hepatic injury in an ex vivo rat model of warm and cold ischemia. Liver Transpl (2007) 1.53
Toll-like receptor and heme oxygenase-1 signaling in hepatic ischemia/reperfusion injury. Am J Transplant (2005) 1.51
Treating hepatitis C in the prison population is cost-saving. Hepatology (2008) 1.50
Liver transplantation using organ donation after cardiac death: a clinical predictive index for graft failure-free survival. Arch Surg (2011) 1.50
Allograft rejection by primed/memory CD8+ T cells is CD154 blockade resistant: therapeutic implications for sensitized transplant recipients. J Immunol (2002) 1.50
MELD score predicts 1-year patient survival post-orthotopic liver transplantation. Liver Transpl (2003) 1.49